| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167 |
| filingDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d49f9ae91044d695aa7aed20c4f8057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b49f5e19de47ada498e5a283d517a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571d790e60f8c52da323e4d6997ae3f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f1e8f63f0d60bdadb5f259545f8a276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beafc93ca18f94099c8c05e58b34bb19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_258e6f7e316fd84ff223d4af98a450e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105465aa5648695e70347af77c3bb0f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3c0251b0560dde48bce3bac83af98b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be497fb654d30d580692f14419466396 |
| publicationDate |
2021-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11059850-B2 |
| titleOfInvention |
Spirobicyclic analogues |
| abstract |
The present invention relates to novel spirobicyclic analogues of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702441-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021380627-A1 |
| priorityDate |
2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |